share_log

Merrimack Pharmaceuticals(MACK.US)董事增持4.96万股普通股股份,价值约65.18万美元

Merrimack Pharmaceuticals(MACK.US) Director Buys US$651.75K in Common Stocks

Futu News ·  Dec 29, 2023 05:18

$Merrimack Pharmaceuticals (MACK.US)$ Director Andersen Eric purchased 49,550 shares of Common Stocks on Dec 26, 28, 2023 at an average price of $13.1535 for a total value of $651.75K.

This transaction involves other related parties: Western Standard LLC, WESTERN STANDARD PARTNERS LP and Western Standard Partners QP, L.P..

1703798308065025786.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment